Developing trustworthy recommendations as part of an urgent response (1–2 weeks): a GRADE concept paper

[1]  J. Sorbello.  Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19 , 2020, Annals of Internal Medicine.

[2]  L. Humphrey,et al.  Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians , 2020, Annals of Internal Medicine.

[3]  E. Akl,et al.  Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19 , 2020, Annals of Internal Medicine.

[4]  E. Akl,et al.  Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19 , 2020, Annals of Internal Medicine.

[5]  L. Humphrey,et al.  Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1) , 2020, Annals of Internal Medicine.

[6]  Reem A Mustafa,et al.  Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  H. Fineberg.  Ten Weeks to Crush the Curve. , 2020, The New England journal of medicine.

[8]  Shazia M. Siddique,et al.  AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic , 2020, Gastroenterology.

[9]  Giuseppe Citerio,et al.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) , 2020, Intensive Care Medicine.

[10]  Roberto Maroldi,et al.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.

[11]  Lanjuan Li,et al.  Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  R. Jin,et al.  Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China , 2020, Current Medical Science.

[13]  P. Tugwell,et al.  Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation , 2020, Systematic Reviews.

[14]  Hongzhou Lu,et al.  Clinical observation and management of COVID-19 patients , 2020, Emerging microbes & infections.

[15]  G. Guyatt,et al.  Evidence vs Consensus in Clinical Practice Guidelines. , 2019, JAMA.

[16]  A. Oxman,et al.  Distinguishing opinion from evidence in guidelines , 2019, BMJ.

[17]  Holger J. Schünemann,et al.  Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. , 2018, Environment international.

[18]  Yuan Zhang,et al.  Development of rapid guidelines: 1. Systematic survey of current practices and methods , 2018, Health Research Policy and Systems.

[19]  Yuan Zhang,et al.  Development of rapid guidelines: 2. A qualitative study with WHO guideline developers , 2018, Health Research Policy and Systems.

[20]  Holger J. Schünemann,et al.  Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations , 2018, Health Research Policy and Systems.

[21]  Claire Glenton,et al.  The GRADE Evidence to Decision (EtD) framework for health system and public health decisions , 2018, Health Research Policy and Systems.

[22]  Lara A Kahale,et al.  Living systematic reviews: 4. Living guideline recommendations. , 2017, Journal of clinical epidemiology.

[23]  P. Tugwell,et al.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both , 2017, British Medical Journal.

[24]  P. Tugwell,et al.  Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment , 2017, Health and Quality of Life Outcomes.

[25]  David Moher,et al.  Developing WHO rapid advice guidelines in the setting of a public health emergency , 2016, Journal of Clinical Epidemiology.

[26]  G. Guyatt,et al.  When and how to update systematic reviews: consensus and checklist , 2016, British Medical Journal.

[27]  Holger J Schünemann,et al.  Using GRADE to respond to health questions with different levels of urgency. , 2016, Environment international.

[28]  G. Guyatt,et al.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines , 2016, British Medical Journal.

[29]  Rachel Churchill,et al.  ROBIS: A new tool to assess risk of bias in systematic reviews was developed , 2016, Journal of clinical epidemiology.

[30]  E. Akl,et al.  The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels , 2015, Implementation Science.

[31]  Romina Brignardello-Petersen,et al.  Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise , 2014, Canadian Medical Association Journal.

[32]  Pablo Alonso-Coello,et al.  Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks , 2014, Implementation Science.

[33]  Günter Ollenschläger,et al.  Guidelines International Network: Toward International Standards for Clinical Practice Guidelines , 2012, Annals of Internal Medicine.

[34]  G. Guyatt,et al.  GRADE guidelines: 8. Rating the quality of evidence--indirectness. , 2011, Journal of clinical epidemiology.

[35]  Gordon H Guyatt,et al.  GRADE guidelines: 2. Framing the question and deciding on important outcomes. , 2011, Journal of clinical epidemiology.

[36]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[37]  Keiji Fukuda,et al.  WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus , 2006, The Lancet Infectious Diseases.

[38]  Paul Garner,et al.  SARS: Systematic Review of Treatment Effects , 2006, PLoS medicine.

[39]  A. Nisbet.  Public Health Protection in Radiation Emergencies , 2019 .

[40]  G. Guyatt,et al.  [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines]. , 2018, Gaceta sanitaria.

[41]  Alonso Carrasco-Labra,et al.  GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. , 2017, Journal of clinical epidemiology.

[42]  H. Schünemann,et al.  [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.] , 2017, Recenti progressi in medicina.

[43]  M. Tirani,et al.  [Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise]. , 2015, Recenti progressi in medicina.

[44]  Statement of EFSA on risks for public health due to the presences of melamine in infant milk and other milk products in China , 2008 .